Oliver Luxxe Assets »

Biosante Pharmaceuticals shares owned by Oliver Luxxe Assets

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Oliver Luxxe Assets from 13F filings

Historical chart of Oliver Luxxe Assets investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Oliver Luxxe Assets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Oliver Luxxe Assets

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 23k 78.94

More positions owned by Oliver Luxxe Assets

Spdr Gold Tr Gold Shs (GLD)
Alphabet Cap Stk Cl A (GOOGL)
Citigroup Com New (C)
Morgan Stanley Com New (MS)
Capital One Financial (COF)
Philip Morris International (PM)
Ralph Lauren Corp Cl A (RL)
Ge Aerospace Com New (GE)
3M Company (MMM)
Ge Vernova (GEV)
Mueller Industries (MLI)
Abbvie (ABBV)
Meta Platforms Cl A (META)
Wells Fargo & Company (WFC)
Jones Lang LaSalle Incorporated (JLL)

View all positions for Oliver Luxxe Assets

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Global Alpha Capital Management
Citadel Advisors
UBS Group
Dimensional Fund Advisors
Geode Capital Management
Deep Track Capital
Point72 Asset Management
Nuveen
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
William Blair Investment Management
Rubric Capital Management

View all funds holding Biosante Pharmaceuticals